We are live on
!
Find out more
AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$332M
1-Year Est. Return
12.78%
This Fund
S&P 500
This Quarter
Est. Return
+11.04%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$371M
AUM Growth
-$37.3M
(-9.1%)
Cap. Flow
-$67.8M
Cap. Flow
% of AUM
-18.28%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
167
New
21
Increased
20
Reduced
78
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aaon
AAON
|
+$6.63M |
| 2 |
Privia Health
PRVA
|
+$3.97M |
| 3 |
Cadre Holdings
CDRE
|
+$3.79M |
| 4 |
EXL Service
EXLS
|
+$3.72M |
| 5 |
BCPC
Balchem Corp
BCPC
|
+$3.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Grocery Outlet
GO
|
+$6.47M |
| 2 |
FTAI Aviation
FTAI
|
+$5.97M |
| 3 |
ESCO Technologies
ESE
|
+$4.78M |
| 4 |
Agilysys
AGYS
|
+$4.33M |
| 5 |
Construction Partners
ROAD
|
+$4.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 36.07% |
| 2 | Technology | 22.78% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Healthcare | 10.46% |
| 5 | Materials | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Riot Platforms
RIOT
$7.63B
| $462K | 0.12% |
40,902
-9,736
| -19% | -$82.8K |
|
102
Collegium Pharmaceutical
COLL
$1.15B
| $459K | 0.12% |
15,531
-3,630
| -19% | -$104K |
|
103
CleanSpark
CLSK
$3.53B
| $405K | 0.11% |
36,753
-8,782
| -19% | -$78.2K |
|
104
MiMedx Group
MDXG
$602M
| $403K | 0.11% |
66,124
-15,505
| -19% | -$103K |
|
105
Krystal Biotech
KRYS
$10.1B
| $398K | 0.11% |
2,894
-675
| -19% | -$99.1K |
|
106
Protagonist Therapeutics
PTGX
$8.79B
| $385K | 0.1% |
6,972
-1,662
| -19% | -$79.8K |
|
|
CPRX
107
DELISTED
Catalyst Pharmaceutical
CPRX
| $352K | 0.09% |
16,200
-3,837
| -19% | -$90.6K |
|
108
Castle Biosciences
CSTL
$849M
| $327K | 0.09% |
16,021
-3,784
| -19% | -$70.1K |
|
|
DVAX
109
DELISTED
Dynavax Technologies
DVAX
| $309K | 0.08% |
31,158
-7,285
| -19% | -$76.8K |
|
110
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $305K | 0.08% |
11,020
-2,577
| -19% | -$65.6K |
|
111
Acadia Pharmaceuticals
ACAD
$4.43B
| $273K | 0.07% |
12,643
-2,958
| -19% | -$55K |
|
112
Marathon Digital Holdings
MARA
$4.32B
| $236K | 0.06% |
15,069
-3,632
| -19% | -$52K |
|
113
Interparfums
IPAR
$3.99B
| $208K | 0.06% |
+1,584
| New | +$194K |
|
114
Ligand Pharmaceuticals
LGND
$5.76B
| $207K | 0.06% |
+1,823
| New | +$195K |
|
115
Arrowhead Research
ARWR
$11.9B
| $204K | 0.06% |
+12,938
| New | +$186K |
|
116
Aurinia Pharmaceuticals
AUPH
$1.91B
| $204K | 0.06% |
+24,079
| New | +$193K |
|
117
PTC Therapeutics
PTCT
$5.64B
| $204K | 0.06% |
+4,174
| New | +$198K |
|
118
Stoke Therapeutics
STOK
$1.8B
| $203K | 0.05% |
+17,888
| New | +$170K |
|
|
FOLD
119
DELISTED
Amicus Therapeutics
FOLD
| $201K | 0.05% |
+35,082
| New | +$226K |
|
120
Ameris Bancorp
ABCB
$5.85B
| – | – |
-3,792
| Closed | -$218K |
|
121
Associated Banc-Corp
ASB
$5.83B
| – | – |
-9,523
| Closed | -$215K |
|
122
Axos Financial
AX
$5.77B
| – | – |
-3,321
| Closed | -$214K |
|
|
AZEK
123
DELISTED
The AZEK Co
AZEK
| – | – |
-36,266
| Closed | -$1.77M |
|
124
BancFirst
BANF
$3.79B
| – | – |
-2,279
| Closed | -$250K |
|
125
Bankunited
BKU
$3.37B
| – | – |
-6,476
| Closed | -$223K |
|
Similar funds
CPA
PAWA
EE
GB
SC
SFG
PA
BCCM
Advantage Alpha Capital Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Advantage Alpha Capital Partners held 167 positions worth $371M, down 9.1% from $408M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Advantage Alpha Capital Partners withdrew a net $67.8M in Q2 2025, closing 48 positions and reducing 78 holdings. Its most notable exit was Grocery Outlet, an estimated $6.47M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 36% of assets, up from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Advantage Alpha Capital Partners opened a new position in Aaon worth $5.57M.
- Advantage Alpha Capital Partners's largest Q2 2025 buy was Aaon: 75,586 shares worth $5.57M.
- Advantage Alpha Capital Partners added most to Trex in Q2 2025, an estimated $2.67M increase.
- Advantage Alpha Capital Partners's biggest Q2 2025 reduction was FTAI Aviation, cutting an estimated $5.97M.
- Advantage Alpha Capital Partners fully exited Grocery Outlet in Q2 2025, selling an estimated $6.47M.
- Advantage Alpha Capital Partners's ten largest holdings make up 18% of its $371M portfolio in Q2 2025.
- Advantage Alpha Capital Partners opened 21 new positions and closed 48 in Q2 2025.
- Advantage Alpha Capital Partners's portfolio value fell 9.1% quarter-over-quarter to $371M.
Based on Advantage Alpha Capital Partners's 13F filing for Q2 2025, filed 13 Aug 2025.